Buprenorphine: a controlled clinical trial in the treatment of opioid dependence.
about
Baclofen for maintenance treatment of opioid dependence: a randomized double-blind placebo-controlled clinical trial [ISRCTN32121581]Impact of Chronic Pain on Treatment Prognosis for Patients with Opioid Use Disorder: A Systematic Review and Meta-analysisAn intronic variant in OPRD1 predicts treatment outcome for opioid dependence in African-AmericansA polymorphism in the OPRM1 3'-untranslated region is associated with methadone efficacy in treating opioid dependenceBuprenorphine versus dihydrocodeine for opiate detoxification in primary care: a randomised controlled trial.Practical considerations for the clinical use of buprenorphine.Understanding attitudes towards use of medication in substance abuse treatment: A multilevel approach.Bringing buprenorphine-naloxone detoxification to community treatment providers: the NIDA Clinical Trials Network field experience.Emerging adult age status predicts poor buprenorphine treatment retention.The effectiveness of community maintenance with methadone or buprenorphine for treating opiate dependence.Predictors of buprenorphine initial outpatient maintenance and dose taper response among non-treatment-seeking heroin dependent volunteersA comparison of buprenorphine induction strategies: patient-centered home-based inductions versus standard-of-care office-based inductions.Timing of buprenorphine adoption by privately funded substance abuse treatment programs: the role of institutional and resource-based interorganizational linkages.Treating opioid addiction with buprenorphine-naloxone in community-based primary care settingsThe adoption of medications in substance abuse treatment: associations with organizational characteristics and technology clustersComparison of demographic and clinical characteristics between opioid-dependent individuals admitted to a community-based treatment setting and those enrolled in a research-based treatment setting.Heroin-dependent inmates' experiences with buprenorphine or methadone maintenance.Mood and Global Symptom Changes among Psychotherapy Clients with Depressive Personality.Patient characteristics associated with buprenorphine/naloxone treatment outcome for prescription opioid dependence: Results from a multisite study.Meta-analysis of depression and substance use and impairment among intravenous drug users (IDUs)A meta-analysis of retention in methadone maintenance by dose and dosing strategy.Predictors of attrition with buprenorphine/naloxone treatment in opioid dependent youth.Genetic variation in OPRD1 and the response to treatment for opioid dependence with buprenorphine in European-American females.Retention rate and substance use in methadone and buprenorphine maintenance therapy and predictors of outcome: results from a randomized study.Use of microdoses for induction of buprenorphine treatment with overlapping full opioid agonist use: the Bernese methodA prospective, randomized, multicenter acceptability and safety study of direct buprenorphine/naloxone induction in heroin-dependent individuals.Do methadone and buprenorphine have the same impact on psychopathological symptoms of heroin addicts?Buprenorphine in the treatment of opiate dependence.Buprenorphine versus methadone maintenance treatment in an ambulant setting: a health-related quality of life assessment.Controlled, randomized trial in maintenance treatment of intravenous buprenorphine dependence with naltrexone, methadone or buprenorphine: a novel study.
P2860
Q24799720-4C6B700F-4526-45DA-BCFF-BFFBBF86BAB3Q26785010-3A8229CD-4ED6-406B-BB45-110581445E64Q30543145-A287E6C2-DDDF-4DE8-AC61-5FB3D461D836Q30855550-42C854E7-0679-4BF6-A4D8-3A1274836787Q33268544-503F170D-1A91-499B-968E-18C18278B808Q33774853-F1C60868-F045-4669-9E42-D0550168BBFAQ33791771-E6CFF2C8-6337-40A4-8353-5B306269E4E1Q34081656-2D9E0885-E701-4EB3-9B14-63D3CF06CC84Q34269194-525CD991-5304-4F7E-B602-4D39EC0DAB5EQ34620483-30C05D8F-2374-49AF-AA4C-1BEE02FBC0F8Q34749223-CF5292A3-812B-41DA-9A07-F9D3C7105823Q34850334-A362419A-A594-4A20-ACC8-BDD401E96173Q35577449-200EA830-E56B-4B01-A891-ED83EC235134Q35721931-5688F7F6-66E1-4012-9A59-0FE38635C1FFQ35792939-4536C766-A33E-4360-9494-8D49BD8EF49EQ36326197-32100D3D-65C4-41AF-9217-7A340DF7B8CBQ36480967-63F72D0C-61E9-47BC-9652-E839F1270F67Q36490394-B5B8876A-2E27-4816-9770-EA09C2D10AB5Q36800122-974B9180-A655-4EC6-8F1D-CBFB6043ED55Q36894307-308967C9-FEF8-4502-8A43-8C7FE1D96152Q36946147-4512E4E7-1155-412E-BCC8-B467A6D99C22Q36952763-5AAF238C-F7A6-4D9F-9ACB-DD53976FC5C8Q37705283-013C2172-DAC3-4408-8DB7-9E8A116A3C03Q40132985-26D2D66D-652F-4E60-81CD-AA544B143F54Q42406269-3BF4EF14-C01E-4F18-B5DB-474454EFB120Q42608727-FD55EDA4-3300-4002-84BA-6F83ECD0171BQ42754294-DC66207C-043C-439E-B8A2-61860FC6450BQ42962930-500BB628-17B4-4367-838E-EA876F17EAC1Q44444205-C51FB716-41B0-4D76-9EBA-F3B9FB1BF222Q44553367-3DB11198-F700-41BD-A0D0-85B0808EEF50
P2860
Buprenorphine: a controlled clinical trial in the treatment of opioid dependence.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh-hant
name
Buprenorphine: a controlled clinical trial in the treatment of opioid dependence.
@en
Buprenorphine: a controlled clinical trial in the treatment of opioid dependence.
@nl
type
label
Buprenorphine: a controlled clinical trial in the treatment of opioid dependence.
@en
Buprenorphine: a controlled clinical trial in the treatment of opioid dependence.
@nl
prefLabel
Buprenorphine: a controlled clinical trial in the treatment of opioid dependence.
@en
Buprenorphine: a controlled clinical trial in the treatment of opioid dependence.
@nl
P2093
P1476
Buprenorphine: a controlled clinical trial in the treatment of opioid dependence.
@en
P2093
A Tagliamonte
I Maremmani
P356
10.1016/S0376-8716(99)00140-4
P577
2000-07-01T00:00:00Z